COMMUNIQUÉS West-GlobeNewswire

-
Aurora Spine Completes Private Placement
09/02/2018 -
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017
09/02/2018 -
Cytori Therapeutics Announces Inducement Grants for New Employees
09/02/2018 -
AFA: Increased Spending at the NIH Paves the Way for a Much-Needed Boost to Funding for Alzheimer’s Research
09/02/2018 -
HealthEquity’s Jon Soldan Named to Utah Business’ Forty Under 40
09/02/2018 -
RavenQuest Acquires Remaining Shares Under Alberta Green Biotech Acquisition
09/02/2018 -
BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Patients with Urothelial Carcinoma at 2018 Genitourinary Cancers Symposium
09/02/2018 -
Aviragen Adjourns Special Meeting of Stockholders to Allow Stockholders to Consider Improved Merger Deal Terms
09/02/2018 -
INSYS Therapeutics Addresses Maryland Attorney General’s Motion
09/02/2018 -
American College of Rheumatology Praises Congressional Leaders for Passing Spending Bill that Includes Part B Fix, Therapy Caps Repeal
09/02/2018 -
LifePoint Health To Broadcast Its Fourth Quarter And Year-End 2017 Conference Call Live On The Internet
09/02/2018 -
BioStem Technologies Inc. Announces New Transfer Agent, V Stock Transfer
09/02/2018 -
Chiesi USA, Inc. Certified As a Top Employer in the US for Third Consecutive Year
09/02/2018 -
LB-100 and LB-102, Lixte Biotechnology’s Protein Phosphatase 2A Inhibitors, Sensitize BCR-ABL Leukemia Stem Cells to Targeted Therapy with Tyrosine Kinase Inhibitors
09/02/2018 -
Sienna Senior Living Inc. Announces Closing of Common Share Offering for Gross Proceeds of Approximately $160 Million
09/02/2018 -
Canada House Wellness Group’s COO, Riley McGee Interviewed on the Midas Letter
09/02/2018 -
Oncobiologics Announces Term Extension of Series A Warrants
09/02/2018 -
Precipio Announces Q4 2017 Revenue at 350% of Previous Quarter
09/02/2018 -
Two New Studies Demonstrate T2Candida’s Advantages over Current Diagnostic Testing
09/02/2018
Pages